Skip to main content
logo
Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.1500
0.00 (0.00%)
Oct 27, 2025, 8:00 PM EDT

Orgenesis Revenue

Orgenesis had revenue of $347.00K in the quarter ending September 30, 2024, with 215.45% growth. This brings the company's revenue in the last twelve months to $899.00K, down -93.57% year-over-year. In the year 2023, Orgenesis had annual revenue of $530.00K, down -98.53%.

Revenue (ttm)
899.00K
Revenue Growth
-93.57%
P/S Ratio
1.10
Revenue / Employee
6.16K
Employees
146
Market Cap
985.22K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2023530.00K-35.50M-98.53%
Dec 31, 202236.03M523.00K1.47%
Dec 31, 202135.50M27.85M363.96%
Dec 31, 20207.65M3.75M96.26%
Dec 31, 20193.90M-18.33M-82.46%
Dec 31, 2018 Pro Pro Pro
Nov 30, 2017 Pro Pro Pro
Nov 30, 2016 Pro Pro Pro
Nov 30, 2015 Pro Pro Pro
Nov 30, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings256.36M
Glass House Brands221.55M
Elite Pharmaceuticals105.45M
Silence Therapeutics27.17M
Nuo Therapeutics1.95M
Northwest Biotherapeutics1.09M
Revenue Rankings

Orgenesis News

More News